What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
His primary areas of investigation include Immunology, Immune system, Dermatology, Psoriasis and Cancer research.
His studies deal with areas such as Interleukin 12 and In vivo as well as Immunology.
His Immune system study combines topics from a wide range of disciplines, such as Inflammation, Angiogenesis and Immunopathology.
The Vitiligo and PUVA therapy research he does as part of his general Dermatology study is frequently linked to other disciplines of science, such as Ultraviolet light and Localised scleroderma, therefore creating a link between diverse domains of science.
His research in Psoriasis intersects with topics in Interleukin and STAT1.
The Cancer research study combines topics in areas such as Interleukin 23 and Cell cycle.
His most cited work include:
- Simultaneous PET-MRI: a new approach for functional and morphological imaging (794 citations)
- Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study (621 citations)
- Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. (556 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Immunology, Dermatology, Immune system, Cancer research and Pathology.
As part of his studies on Immunology, Martin Röcken often connects relevant areas like Cytotoxic T cell.
His research in Immune system focuses on subjects like Inflammation, which are connected to Pharmacology.
The study incorporates disciplines such as Immune checkpoint, Senescence and Downregulation and upregulation in addition to Cancer research.
His studies in Psoriasis integrate themes in fields like Multiple sclerosis and Atopic dermatitis.
His Melanoma research includes elements of Internal medicine, Metastasis and Oncology.
He most often published in these fields:
- Immunology (30.48%)
- Dermatology (19.70%)
- Immune system (18.96%)
What were the highlights of his more recent work (between 2016-2021)?
- Cancer research (17.10%)
- Immune system (18.96%)
- Melanoma (11.90%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Cancer research, Immune system, Melanoma, Immunotherapy and Immunology.
Martin Röcken has researched Cancer research in several fields, including Immune checkpoint, Senescence, Downregulation and upregulation, Antigen and Lymphoma.
His Immune system research is multidisciplinary, incorporating perspectives in Cancer, Cytokine and Pathology.
His work carried out in the field of Melanoma brings together such families of science as Internal medicine, Interquartile range, CDKN2A and Oncology.
His work in Immunotherapy addresses subjects such as Cancer cell, which are connected to disciplines such as T cell.
His study in the field of Adoptive cell transfer is also linked to topics like HLA-B27.
Between 2016 and 2021, his most popular works were:
- Survival of Patients with Cutaneous Squamous Cell Carcinoma: Results of a Prospective Cohort Study (46 citations)
- Reversal of tumor acidosis by systemic buffering reactivates NK cells to express IFN-γ and induces NK cell-dependent lymphoma control without other immunotherapies. (36 citations)
- Immune checkpoint blockade therapy (30 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
Immune system, Cancer research, Cancer, Immunotherapy and Immune checkpoint are his primary areas of study.
His Immune system research focuses on Pathology and how it connects with Hypoxia, Ex vivo and Reactive oxygen species.
His Cancer research research includes themes of Downregulation and upregulation, Antigen, Lymphatic system, MHC class I and Effector.
His biological study spans a wide range of topics, including Spleen, Red pulp, White pulp and Germinal center.
As a part of the same scientific study, Martin Röcken usually deals with the Immunotherapy, concentrating on Cancer cell and frequently concerns with Melanoma.
Martin Röcken has included themes like CTLA-4, CTL* and PD-L1 in his Immune checkpoint study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
